Interaction of Blood Pressure and Glycemic Status in Developing Cardiovascular Disease: Analysis of a Nationwide

Yuta Suzuki1,2, Hidehiro Kaneko1,3, Yuichiro Yano4,5

  • 1The Department of Cardiovascular Medicine The University of Tokyo Tokyo Japan.

Insights

Hypertension and hyperglycemia additively increase cardiovascular disease risk. However, their individual contributions diminish as the other condition worsens, indicating a complex interaction.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Hypertension and diabetes often coexist, but their combined impact on cardiovascular disease (CVD) development is not fully understood.
  • Existing research has limited insight into the interaction between elevated blood pressure (BP) and hyperglycemia in CVD pathogenesis.

Purpose of the Study:

  • To investigate the additive and interactive effects of hypertension and hyperglycemia on the risk of developing various cardiovascular events.
  • To quantify how worsening glycemic status affects hypertension-related CVD risk and how increasing BP affects hyperglycemia-related CVD risk.

Main Methods:

  • An observational cohort study involving 3,336,363 patients without prior CVD or use of BP/glucose-lowering medications.
  • Categorization of hypertension (Stage 1 and Stage 2) and glycemic status (normal, prediabetes, diabetes) based on defined BP and fasting plasma glucose levels.
  • Analysis of the incidence of myocardial infarction, angina pectoris, stroke, heart failure, and atrial fibrillation over a mean follow-up of approximately 3.25 years.

Main Results:

  • Both elevated BP and hyperglycemia independently and additively increased the risk of all studied cardiovascular events.
  • The relative risk of hypertension-related CVD decreased as glycemic status worsened (e.g., Stage 2 hypertension showed reduced heart failure risk with prediabetes and diabetes compared to normal glucose levels).
  • The relative risk of hyperglycemia-related CVD attenuated as BP increased (e.g., diabetes showed reduced CVD risk with increasing BP categories).

Conclusions:

  • Hypertension and hyperglycemia act additively to elevate cardiovascular disease risk.
  • A significant interaction exists where the relative contribution of hypertension to CVD risk decreases with worsening hyperglycemia, and vice versa.
  • These findings highlight the complex interplay between blood pressure and glucose metabolism in cardiovascular health.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.4K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
823
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
35